Acer Therapeutics Inc. ACER
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for ACER has not been loaded yet. Try again in a moment.
Altman Z-Score
-29.87 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -1.4×
P/S 0.0×
P/B -2.4×
P/FCF -1.3×
EV/EBITDA -1.9×
EV/Sales 0.0×
FCF Yield -76.9%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 156.5%
ROIC 502.6%
ROA -225.7%
Revenue -100.0%
Operating Income -54.3%
EPS (diluted) -71.8%
Free Cash Flow -15924.5%
Current Ratio 0.2×
Quick Ratio 0.2×
Debt / Equity -0.7×
Net Debt / EBITDA -0.4×
Interest Coverage -243×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31